Concepedia

Tetraethylthiuram disulphide alleviates pulmonary fibrosis through modulating transforming growth factor-β signalling

Hongchao Jiang, Yaxue Zhao, Huirong Tang, Shixin Duan, Mengkai Li, Xinyi Yang, Jingting Liu, Xinyi Lou, Yuanyuan Cai, Wenjuan Zhao,

Pharmacological Research · 2021 · 11 citations · 48 references

DOI

Concepts

References

48

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

, , +13

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline

Ganesh Raghu, Bram Rochwerg, Yuan Zhang et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 1.9K citations

, , +11

FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation

Jun Hu, Xing Liu, Shiyu Xia et al. · Nature Immunology · 2020 · 1.1K citations · Full text

, , +5

Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.

Patricia J. Sime, Frank L. Graham, Karl G. Csaky et al. · Journal of Clinical Investigation · 1997 · 1K citations · Full text

, , +17

Pirfenidone in idiopathic pulmonary fibrosis

H. Taniguchi, Masahito Ebina, Yasuhiro Kondoh et al. · European Respiratory Journal · 2009 · 946 citations · Full text

, , +12